Are you Dr. Gansner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3779
Summary
- Dr. John Gansner, MD is an oncologist in Boston, Massachusetts. He is a Clinical Fellow in Medicine at Brigham and Women's Hospital.
Publications & Presentations
PubMed
- 2 citationsEfficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial.Jeffrey M Saland, John C Lieske, Jaap W Groothoff, Yaacov Frishberg, Hadas Shasha-Lavsky
Kidney International Reports. 2024-07-01 - Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial.Yaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, David J Sas, Mini Michael
Frontiers in Pediatrics. 2024-01-01 - 2 citationsQuantification of oxalate by novel LC-MS/MS: assay development, validation and application in lumasiran clinical trials.Valerie A Clausen, Karen H Cao, John M Gansner, Gabriel J Robbie, Jing-Tao Wu
Bioanalysis. 2023-05-01